24.12.2018 Views

FM OCTOBER 2018 ISSUE - digital edition

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

However, at age 4, the<br />

child was brought to Lilawati<br />

Hospital and Research DURING DISCUSSIONS<br />

Center, Mumbai, to consult WITH OTHER DOCTORS, SHE<br />

with Dr. Swati Kanakia, a REALIZED THAT PERHAPS<br />

pediatric hemato-oncologist.<br />

HER CHOICE OF KEYWORDS<br />

The patient presented with<br />

WAS NOT CORRECT.<br />

bleeding in the skin, another<br />

intracranial hemorrhage,<br />

and low platelet count. An<br />

MRI showed calcification in<br />

the basal ganglia and evidence of the previous intracranial<br />

bleeding. Based on the history, the patient was started on<br />

IVIg for treating low platelets. Further, even though normally<br />

platelets are not given as therapy in such cases as they<br />

would be expected to be destroyed in the body, this patient<br />

was again given platelets as well because of the intracranial<br />

hemorrhage, and started with cyclosporine syrup.<br />

In addition, Dr. Kanakia observed certain morphological<br />

abnormalities including short stature, high arched palate,<br />

low set ears, and wider wrists than normal. Wider wrists are<br />

typical signs of rickets and an X-ray of the wrist was done<br />

which indeed showed typical signs of rickets. Blood tests<br />

for vitamin D, calcium, and phosphorous however did not<br />

corroborate with the clinical findings for rickets.<br />

This was indeed an atypical case where the patient<br />

had an early onset of ITP, was not responsive to treatment<br />

over long periods of time, had two intracranial hemorrhages,<br />

calcification of basal ganglia and showed signs of<br />

abnormal facies. In addition to these, she was strongly<br />

positive for alloantibodies against red blood cells as<br />

evidenced in a direct Coomb’s test and thyroid antibodies<br />

causing hypothyroidism. Such autoantibodies are<br />

evidence of autoimmunity. Dr. Kanakia was not satisfied<br />

with the diagnosis and treatment being offered to the<br />

patient, and continued to search for a more accurate<br />

diagnosis and better treatment options. She searched the<br />

OMiM database for other similar cases, but was not able to<br />

come up with anything similar. During discussions with other<br />

doctors, she realized that perhaps her choice of keywords<br />

was not correct. She was including the<br />

keyword ‘rickets’ due to the wider wrists<br />

that are characteristic of rickets. However,<br />

once she replaced ‘rickets’ with ‘metaphyseal<br />

dysplasia’, she was able to find a very similar<br />

condition called spondyloenchondrodysplasia<br />

with immune dysregulation (SPENCDI).<br />

As per the description, ‘SPENCDI is an<br />

immunoosseous dysplasia combining the<br />

typical metaphyseal and vertebral bone<br />

lesions of spondyloenchondrodysplasia<br />

(SPENCD) with immune dysfunction and<br />

neurologic involvement’ The patient’s<br />

condition seemed to fit well with the<br />

description.<br />

SPENCDI is caused by a homozygous<br />

mutation in the APC5gene on chromosome<br />

19p13. Genetic testing was carried out, and<br />

consistent with the clinical symptoms, the<br />

patient was found to carry a homozygous<br />

deletion in the APC gene that results in a<br />

truncated protein. The patient’s parents also<br />

underwent genetic testing, and they were<br />

found to carry the heterozygous mutations.<br />

Based on this genetic identification, the<br />

patient had a confirmed diagnosis of<br />

SPENCDI and was accordingly continued on<br />

cyclosporine. The dosage of cyclosporine<br />

was kept at a minimum dose just to maintain<br />

the platelet levels at a safe count of 30,000-<br />

40,000/uL. The patient is doing well as of<br />

now.<br />

The genetic identification was not only<br />

important for adequate treatment and<br />

management of the patient, but would also<br />

be important in case the parents decided to<br />

have another child. Prenatal testing can be<br />

used to determine whether the child would<br />

be homozygous or heterozygous, allowing<br />

for the option to terminate the pregnancy if<br />

required. Such prenatal testing may therefore<br />

prevent another child with the same genetic<br />

disorder. Genetic testing can also be done for<br />

close family members to assess hereditary<br />

mutations.<br />

“Accurate diagnosis gives the patient/<br />

patient’s family a sense of closure and helps<br />

them prepare for their next child. Even in<br />

this age of technological advances, clinical<br />

judgement is extremely important. To be<br />

able to diagnose accurately, it is important to<br />

understand which tests to run,” Dr. Kanakia<br />

shares her learnings from this case.<br />

DR SHIVANEE SHAH<br />

<strong>OCTOBER</strong> <strong>2018</strong> / FUTURE MEDICINE / 57

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!